Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy April 16, 2018
Affimed Announces Fourth Quarter and Year End 2017 Financial Results and Corporate Update Conference Call March 13, 2018
Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares February 15, 2018
